DrugPatentWatch Database Preview
Profile for Canada Patent: 2763894
US Patent Family Members and Approved Drugs for Canada Patent: 2763894
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jul 24, 2029 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Mar 10, 2030 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Jul 24, 2029 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Jul 24, 2029 | Salix Pharms | XIFAXAN | rifaximin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |